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One of the major concerns associated with the use of influenza virus-like particles (VLPs) produced in cell 
culture as vaccine candidates is their heterogeneous composition. Enveloped VLPs take up the host cell 
membrane at the budding site carrying out with them not only the viral antigenic proteins but also host cell 
proteins. In addition, the intrinsic nature of the cells to produce membrane derived vesicles which have similar 
size to the VLPs and can also contain the antigenic proteins, makes the VLP purification process challenging. 
Certainly, the expression system and the viral recombinant proteins employed will determine the nature of the 
proteins within the VLPs. To further characterize cell culture produced-influenza VLPs and contribute to enable 
their approval as vaccine candidates, the composition and biogenesis of VLPs need to be better understood. In 
this study we have characterized, by nanoscale liquid chromatography tandem mass spectrometry (n-LC-
MS/MS), influenza H1N1 Gag-VLPs produced in human embryonic kidney cells adapted to serum-free medium 
(HEK-293SF). The cells stably express HA and NA, and the VLPs production occurs following transient 
transfection with a plasmid containing the gag gene of HIV-1 fused to GFP.  Extracellular vesicles (EVs) 
produced by the unmodified HEK-293SF were also characterized by n-LC-MS/MS. A total of 73 host cell 
proteins were identified in the VLPs, whereas 98 were detected in the extracellular vesicles. From that, 32 host 
cell proteins were unique to VLPs while 41 proteins were found in both.  Importantly, nucleolin was the most 
abundant host cell differential protein identified in VLPs while lactotransferrin and heat shock protein 90 were 
the most present in EVs. This study provides a detailed proteomic description of the VLPs and EVs produced in 
HEK-293SF as well as a critical discussion of the function of each protein incorporated in both nanoparticles 
species. The outcome of this research also sheds light on unique target proteins differentially identified either in 
VLPs and EVs that could potentially be exploited for the development of novel purification protocols to separate 
EVs from VLPs. 
 
 
 
